The dilemma of T1 esophageal adenocarcinoma

J Thorac Cardiovasc Surg. 2017 May;153(5):1206-1207. doi: 10.1016/j.jtcvs.2016.10.106. Epub 2017 Feb 16.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adenocarcinoma / mortality
  • Adenocarcinoma / pathology
  • Adenocarcinoma / surgery*
  • Clinical Competence
  • Clinical Decision-Making
  • Esophageal Neoplasms / mortality
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / surgery*
  • Esophagectomy / adverse effects
  • Esophagectomy / methods*
  • Esophagectomy / mortality
  • Hospitals, High-Volume
  • Humans
  • Neoplasm Staging
  • Organ Sparing Treatments* / adverse effects
  • Organ Sparing Treatments* / mortality
  • Patient Selection
  • Quality of Life
  • Recovery of Function
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Supplementary concepts

  • Adenocarcinoma Of Esophagus